Methods of treating tuberous sclerosis complex with cannabidiol and everolimus
US11160795B2 · kind B2 · utility
34Cited by
18References
29Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 1, 2021 |
| Grant date | Nov 2, 2021 |
| Priority date | — |
| Expiry date | Mar 1, 2041 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2236/53
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure provides methods of treating tuberous sclerosis complex comprising administering cannabidiol and everolimus.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.